Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$36.72 USD
+0.21 (0.58%)
Updated May 24, 2024 04:00 PM ET
After-Market: $36.70 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Biohaven Ltd. [BHVN]
Reports for Purchase
Showing records 21 - 40 ( 268 total )
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Biotechnology- Survey Says... Annual Migraine Physician Survey Says More Room to Grow
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker - Week Ending 6/3/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker - Week Ending 5/27/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 5/20/22
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Zavegepant Acceptance - Check; Troriluzole SCA Data Not Central To Deal
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 5/13/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker - Week Ending 5/6/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Pfizer Decides to Own Nurtec; Downgrade to Neutral on Acquisition
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Couldn''t Have Come At A Better Time - PFE To Acquire BHVN For $12B
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Key Highlights From The BHVN/PFE Investor Call - Deal Makes Sense From Our View
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
1Q22 Commercial Biotech Preview: Let''s Get It Over With
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Biotechnology- Weekly Neurology Prescription Sales Tracker
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 4/1/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Will The Beat Go On? Revisiting Past Nurtec ODT History
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 3/11/22
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L